Eleuthra Photonics provides expertise to MarginDx project

EnterpriseWorks startup Eleuthra Photonics will provide industry and translation expertise for the Margin Diagnostics (MarginDx) project.

Funded through the ARPA-H Precision Surgical Interventions (PSI) program, MarginDx combines optical imaging technologies with AI screening tools to ensure, in real-time, that tumor tissue and cells are completely removed during surgery. A large team of researchers and clinicians from the University of Illinois Urbana-Champaign, Mayo Clinic, Eleuthra Photonics, and other industry and clinical collaborators are working to find an end-to-end solution that will drastically improve surgical outcomes for cancer tumor removal.

Eleuthra Photonics was founded in 2023 and was admitted to the I-Start program at EnterpriseWorks. Eleuthra Photonics specializes in developing and producing rapid image-based diagnostic tools for analyzing tissue and cell samples, with a primary focus on cancer and other disease diagnoses.

Learn more on the University of Illinois Interdisciplinary Health Sciences Institute website.